Cancer Treatment & Specialized Care

Donanemab Cost in 2026: Alzheimer’s Drug Price, Medicare Coverage & Patient Assistance Options

Donanemab (Kisunla), Eli Lilly’s Alzheimer’s therapy, is priced around $32,000 per year in 2024–2025 and may rise slightly by 2026. This guide covers the latest projected prices, Medicare and insurance coverage, out-of-pocket estimates, and patient assistance programs available in the U.S. Compare Donanemab vs Leqembi costs, understand CMS registry requirements, and find financial aid options for Alzheimer’s patients.

36 views October 15, 2025

Donanemab cost 2026 Donanemab price USA Alzheimer’s treatment cost Medicare Alzheimer’s coverage Kisunla price Eli Lilly Donanemab Alzheimer’s drug comparison Leqembi vs Donanemab Alzheimer’s medication assistance Alzheimer’s drug cost breakdown

Imfinzi Cost in the USA 2025: Price, Treatment for Lung Cancer, and Insurance Coverage

Imfinzi Cost in the USA 2025: What Patients Need to Know Imfinzi (durvalumab) has become a vital immunotherapy option for patients with lung cancer in the United States, but its price remains a major concern in 2025. The average cost of a single Imfinzi infusion is estimated at $10,000–$12,000, which means that annual treatment expenses can easily exceed $140,000 per year before insurance or assistance programs are applied. For patients and caregivers, understanding the true cost of Imfinzi involves more than just the drug’s wholesale price. Factors such as insurance coverage, Medicare Part B rules, infusion center administration fees, and manufacturer co-pay assistance all play a role in determining what you will actually pay out-of-pocket. The good news is that programs like AstraZeneca Access 360 and patient savings support can dramatically lower costs, sometimes reducing co-pays to as little as $0 for eligible patients. In this updated 2025 guide, we provide detailed price breakdowns, comparisons with other immunotherapies like Keytruda and Opdivo, insurance coverage insights, and 20 frequently asked questions (FAQs) to help you navigate Imfinzi’s financial impact.

112 views September 29, 2025

Imfinzi cost 2025 durvalumab price USA cost of immunotherapy Imfinzi price per infusion Imfinzi co-pay assistance Imfinzi insurance coverage durvalumab cost comparison immunotherapy cost USA.

Top 10 Most Expensive Cancer Drugs in the U.S. (2025 Update)

In 2025, cancer treatment costs in the United States remain among the highest in the world, with several oncology drugs carrying annual price tags well over $150,000. This article breaks down the Top 10 most expensive cancer drugs in the U.S., comparing per-dose and per-year costs, highlighting manufacturers, and explaining what patients actually pay after insurance. From blockbuster immunotherapies like Keytruda and Imfinzi to groundbreaking CAR-T and gene therapies priced at nearly half a million dollars per treatment, this guide provides a clear look at the latest pricing landscape and practical insights for patients navigating financial support programs.

272 views September 24, 2025

cancer drug costs 2025 most expensive cancer drugs Keytruda cost Opdivo cost Imfinzi price Yervoy cost CAR-T therapy price U.S. cancer treatment cost pembrolizumab price 2025 nivolumab price 2025 oncology drug costs USA cancer treatment insuran

Keytruda Price Per Dose vs. Per Year — Full Breakdown (2025)

Keytruda (pembrolizumab) is one of the most widely prescribed immunotherapy drugs for cancer, but its cost continues to be a major concern for patients in 2025. On average, a single 200 mg intravenous dose is estimated at around $11,700 under Medicare ASP pricing, while a 6-week 400 mg dose carries a published list price of $23,590. Depending on the treatment plan, annual costs can exceed $200,000 per patient. In 2025, Merck also introduced a new subcutaneous formulation (Keytruda QLEX), which offers shorter administration times but could bring different pricing models compared to IV dosing. Insurance coverage, Medicare billing rules, and patient assistance programs remain critical factors in determining real out-of-pocket costs.

323 views September 24, 2025

Keytruda cost Keytruda price 2025 Keytruda per dose cost Keytruda annual cost pembrolizumab price Keytruda insurance coverage Keytruda Medicare Keytruda assistance programs Keytruda subcutaneous QLEX cancer drug costs 2025

Opdivo Cost per Month: Nivolumab Price & Insurance Coverage in the USA (2025)

Opdivo (nivolumab) is one of the most widely used immunotherapy drugs in the United States, but its cost can be overwhelming for many cancer patients. In 2025, the monthly price of Opdivo ranges from $15,000 to over $20,000 before insurance, depending on dosage and treatment schedule. The good news is that Medicare, private insurance, and financial assistance programs can reduce these expenses significantly, sometimes lowering patient out-of-pocket costs to only a few hundred dollars per month. This guide explains the real cost of Opdivo per month, how insurance coverage works, and what assistance options are available to help patients manage treatment expenses.

109 views September 22, 2025

Opdivo cost per month Nivolumab price USA Opdivo insurance coverage cancer immunotherapy cost Opdivo Medicare coverage Opdivo financial assistance Opdivo vs Keytruda cost Opdivo treatment expenses oncology drug pricing USA Opdivo patient assistan

Opdivo Cost in the USA: How Much Does Nivolumab Really Cost in 2025?

In 2025, the cost of Opdivo (Nivolumab) in the United States continues to be a major concern for cancer patients and families. With monthly expenses ranging from $12,000 to $26,000 without insurance, many wonder how they can afford this life-saving immunotherapy. This article explains the true price of Opdivo in 2025, how much insurance covers, available patient assistance programs, and how Opdivo compares to other cancer treatments like Keytruda and Yervoy. You’ll also find updated FAQs with trusted links to help patients make informed financial and medical decisions.

210 views September 13, 2025

Opdivo cost 2025 Nivolumab price USA Opdivo monthly cost immunotherapy drug costs cancer treatment USA Opdivo vs Keytruda Bristol Myers Squibb Opdivo Opdivo insurance coverage

How Much Does Keytruda Cost Per Month?

Keytruda (pembrolizumab) has transformed cancer treatment, but its price tag remains one of the highest in oncology. In 2025, the average monthly cost of Keytruda in the United States is estimated at $15,000 to $16,000, depending on the dosing schedule. While list prices are staggering, most patients do not pay this full amount thanks to insurance coverage, Medicare benefits, and financial assistance programs. Still, questions like “How much does Keytruda cost per month?” and “Why is Keytruda so expensive?” are critical for patients, caregivers, and policymakers navigating the realities of modern cancer care.

360 views September 12, 2025

Keytruda cost Keytruda price per month Keytruda treatment cost Keytruda price USA Keytruda insurance coverage Keytruda Medicare coverage pembrolizumab cost immunotherapy drug prices cancer treatment expenses Keytruda financial assistance why is

Keytruda Price Per Infusion in USA | Updated 2025 Guide

If you or a loved one is considering immunotherapy, understanding the real cost of treatment is crucial. In 2025, the price of Keytruda (pembrolizumab) per infusion in the USA remains a major factor for patients, caregivers, and healthcare providers. On average, a single infusion can cost between $9,800 and $11,500, depending on insurance coverage, treatment duration, and hospital charges. This updated guide explores the latest Keytruda prices, available financial assistance programs, and key insurance considerations to help you plan more effectively. You’ll also find official resources, FAQs, and expert insights, making this one of the most comprehensive guides to Keytruda treatment costs in the USA today.

313 views September 12, 2025

Keytruda cost 2025 Keytruda price USA Keytruda per infusion cost Pembrolizumab cost Keytruda Medicare coverage Keytruda Medicaid cost Keytruda insurance assistance Keytruda co-pay program cancer immunotherapy cost oncology drug prices USA

How Much Does Opdivo Cost in the USA? | Nivolumab Price 2025

In 2025, the cost of Opdivo (nivolumab) in the United States remains a major concern for cancer patients and caregivers. With list prices starting at around $7,600 per infusion and reaching over $36,000 per vial, understanding insurance coverage, financial assistance programs, and the newly approved subcutaneous form (Opdivo Qvantig) is essential. This guide explains the latest prices, cost-saving options, and answers the most common questions about Opdivo treatment in the U.S.

326 views September 11, 2025

Opdivo cost USA 2025 Nivolumab price Opdivo Qvantig Opdivo injection cost cancer immunotherapy cost Opdivo Medicare coverage Bristol Myers Squibb Opdivo Opdivo patient assistance Opdivo vs Yervoy cost immunotherapy drug prices USA Opdivo financi

Keytruda Cost in the USA: How Much Does Pembrolizumab Really Cost in 2025?

Keytruda (pembrolizumab) is one of the most widely used immunotherapy drugs for treating different types of cancer, including lung cancer, melanoma, and head and neck cancers. In the United States, the cost of Keytruda can be a major concern for patients and their families, as it is often priced at several thousand dollars per infusion. This article explores the average cost of Keytruda in the USA, insurance coverage options, financial assistance programs, and helpful resources for patients seeking more affordable access.

798 views September 9, 2025

Keytruda cost USA Keytruda price Keytruda cost lung cancer Keytruda treatment USA pembrolizumab cost Keytruda USA insurance Keytruda financial assistance immunotherapy cost USA Keytruda price per infusion Keytruda USA

Keytruda for Lung Cancer: Cost, Treatment, Survival Rate, and Side Effects

Keytruda (pembrolizumab) is a breakthrough immunotherapy for lung cancer that helps the immune system recognize and attack cancer cells. Unlike chemotherapy, Keytruda targets the PD-1/PD-L1 pathway, improving survival rates in patients with non-small cell lung cancer (NSCLC) and certain cases of small cell lung cancer (SCLC). This guide explains how Keytruda works, its cost, side effects, FDA approval, alternatives, and what patients can expect from treatment.

219 views September 9, 2025

Keytruda lung cancer pembrolizumab lung cancer Keytruda cost Keytruda side effects Keytruda survival rate Keytruda FDA approval Keytruda treatment immunotherapy for lung cancer non small cell lung cancer treatment small cell lung cancer therapy